The Clorox Company (NYSE:CLX) Shares Bought by GAMMA Investing LLC

GAMMA Investing LLC lifted its holdings in shares of The Clorox Company (NYSE:CLX) by 73.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,115 shares of the company’s stock after acquiring an additional 1,320 shares during the quarter. GAMMA Investing LLC’s holdings in Clorox were worth $506,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in CLX. State Street Corp raised its position in Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after purchasing an additional 245,525 shares during the period. Mizuho Securities USA LLC raised its holdings in shares of Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after buying an additional 4,490,421 shares during the period. Geode Capital Management LLC lifted its position in Clorox by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after acquiring an additional 33,970 shares in the last quarter. Stifel Financial Corp boosted its holdings in Clorox by 1.7% in the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after acquiring an additional 37,967 shares during the period. Finally, Nuance Investments LLC grew its position in Clorox by 150.6% in the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after acquiring an additional 960,094 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CLX. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their target price for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Evercore ISI lowered their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Barclays boosted their price target on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research note on Friday, November 1st. DA Davidson increased their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Finally, JPMorgan Chase & Co. lifted their price objective on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Five research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $155.38.

Clorox Stock Performance

Clorox stock opened at $162.89 on Monday. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a fifty day moving average price of $164.58 and a two-hundred day moving average price of $155.02. The company has a market cap of $20.16 billion, a PE ratio of 56.76, a P/E/G ratio of 3.04 and a beta of 0.42.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company’s quarterly revenue was up 27.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.49 EPS. Research analysts expect that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.00%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.